55 studies found for:    IL2RA
Show Display Options
Rank Status Study
1 Recruiting Preemptive Therapy of GVHD
Condition: Graft-vs-host Disease
Intervention: Drug: rabbit antithymocyte globulin
2 Completed
Has Results
Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists
Condition: End Stage Renal Disease
Interventions: Drug: Rabbit Antithymocyte globulin;   Drug: Daclizumab
3 Completed A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndromes
Intervention: Drug: Daclizumab
4 Completed Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab
Condition: Renal Transplantation
Intervention:
5 Recruiting Polymorphisms of Interleukins, Glypican, and Human Leukocyte Antigen Genes and Treatment Response in Multiple Sclerosis.
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Genetic: Polymorphism of Interleukins, Glypican, and Human Leukocyte Antigen Genes.
6 Unknown  Comparison of Alemtuzumab/Tacrolimus Versus Interleukin-2 Receptor (IL-2R) Monoclonal Antibody (MoAb)/Tacrolimus/Mycophenolate in Kidney Transplantation
Conditions: Kidney Transplantation;   Kidney Diseases;   Kidney Failure
Interventions: Drug: Alemtuzumab;   Drug: Daclizumab
7 Completed
Has Results
Anti-Tac for Treatment of Leukemia
Conditions: HTLV-I Infection;   T Cell Leukemia
Intervention: Biological: daclizumab
8 Completed
Has Results
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS
Conditions: Graft vs Host Disease;   Myelodysplastic Syndromes;   Leukemia;   Leukemia, Myeloid;   Leukemia, Myelomonocytic, Chronic;   Leukemia, Lymphocytic;   Lymphoma;   Lymphoma, Mantle-cell;   Lymphoma, Non-Hodgkin;   Hodgkin Disease
Interventions: Drug: RFT5-SMPT-dgA;   Drug: Nexell Isolex system
9 Completed ANTI-TAC THERAPY FOR UVEITIS
Condition: Uveitis
Intervention: Drug: Daclizumab (Zenapax)
10 Enrolling by invitation Clinical Study of the Pharmacogenetic / Pharmacokinetic / Pharmacodynamic Relationships of Calcineurin Inhibitors Cyclosporine and Tacrolimus in Liver Transplant Recipients
Conditions: Liver Transplantation;   Graft Versus Host Disease;   Infection;   Cardiovascular Diseases;   Malignancy
Intervention:
11 Withdrawn Lymphocytic B-Leukemia (B-CLL) w/Human IL-2 Gene Modified & Human CD40 Ligand-Expressing Autologous Tumor Cells
Condition: CHRONIC LYMPHOCYTIC B-LEUKEMIA
Interventions: Biological: IL-2 secreting and hCL4OL-expressing autologous B-CLL cells;   Biological: IL-2;   Biological: CD40L;   Drug: ONTAK;   Biological: immunotoxin dose
12 Completed Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis
Conditions: Ulcerative Colitis;   Gastrointestinal Disease;   Inflammatory Bowel Disease
Intervention: Drug: Daclizumab
13 Completed Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay
Condition: Renal Transplant Recipients
Intervention: Other: Cylex ImmuKnow Assay
14 Completed
Has Results
A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax)
Condition: Kidney Transplantation
Interventions: Biological: DT;   Drug: Daclizumab;   Biological: KLH
15 Active, not recruiting Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Condition: Kidney Transplantation
Interventions: Drug: Advagraf;   Biological: Simulect;   Drug: Cellcept;   Drug: Corticosteroids;   Drug: Ramipril;   Drug: Irbesartan
16 Completed Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Daclizumab
17 Completed
Has Results
A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients
Condition: Renal Transplantation
Interventions: Drug: Everolimus (RAD001);   Drug: Tacrolimus;   Drug: Basiliximab;   Drug: Corticosteroids
18 Completed Zenapax to Treat Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Zenapax
19 Completed
Has Results
A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients
Condition: Kidney Transplantation
Interventions: Drug: CP-690,550;   Drug: tacrolimus
20 Completed
Has Results
A Phase III Study of Abatacept (BMS-188667) in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept;   Drug: Methotrexate;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years